Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-07 Sale |
2025-03-11 8:17 pm |
Y-mAbs Therapeutics Inc. | YMAB | Rossi Michael J PRESIDENT & CEO |
3,917 | $5.2 | $20,368 | 137,083 (Direct) |
View |
| 2025-03-07 Sale |
2025-03-11 8:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas CHIEF BUSINESS OFFICER |
10,810 | $5.23 | $56,536 | 330,402 (Indirect Direct) |
View |
| 2024-09-13 Sale |
2024-09-17 8:05 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas CHIEF BUSINESS OFFICER |
95,000 | $13.31 | $1,264,650 | 286,381 (Indirect Direct) |
View |
| 2024-08-28 Sale |
2024-08-30 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER |
50,000 | $15.37 | $768,500 | 181,262 (Indirect Direct) |
View |
| 2024-08-26 Sale |
2024-08-27 5:05 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wilms Joris SVP & CHIEF OPERATING OFFICER |
5,000 | $14.69 | $73,450 | 30,600 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 7:54 pm |
Y-mAbs Therapeutics Inc. | YMAB | Ber Gerard Director |
722 | $12 | $8,664 | 1,608 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 7:53 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas CHIEF BUSINESS OFFICER |
70,000 | $12.02 | $841,050 | 381,381 (Indirect Direct) |
View |
| 2024-05-30 Sale |
2024-05-31 9:36 pm |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, SECRY & TREAS. |
60,000 | $12.05 | $723,055 | 722,248 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-23 6:54 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas CHIEF BUSINESS OFFICER |
32,351 | $12.23 | $395,563 | 451,381 (Indirect Direct) |
View |
| 2024-03-05 Sale |
2024-03-07 5:02 pm |
Y-mAbs Therapeutics Inc. | YMAB | Rajah Vignesh SVP & CHIEF MEDICAL OFFICER |
1,711 | $16.53 | $28,283 | 38,155 (Indirect Direct) |
View |
| 2024-03-05 Sale |
2024-03-07 5:01 pm |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas CHIEF BUSINESS OFFICER |
3,900 | $16.44 | $64,116 | 483,732 (Indirect Direct) |
View |
| 2024-03-05 Sale |
2024-03-07 4:59 pm |
Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER |
1,682 | $16.55 | $27,837 | 33,918 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-17 Option Award |
2025-01-22 7:05 pm |
N/A 2035-01-17 |
Y-mAbs Therapeutics Inc. | YMAB | PFREUNDSCHUH PETER P. CFO and Treasurer |
95,300 | $0 | 141,300 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 7:04 pm |
N/A 2035-01-17 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas CHIEF BUSINESS OFFICER |
96,000 | $0 | 405,212 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 7:03 pm |
N/A 2035-01-17 |
Y-mAbs Therapeutics Inc. | YMAB | Gentilcore Douglas J SVP, Danyelza Bus. Unit Head |
142,600 | $0 | 142,600 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 7:01 pm |
N/A 2035-01-17 |
Y-mAbs Therapeutics Inc. | YMAB | Wilms Joris SVP & CHIEF OPERATING OFFICER |
64,400 | $0 | 95,000 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 7:00 pm |
N/A 2035-01-17 |
Y-mAbs Therapeutics Inc. | YMAB | Rossi Michael J PRESIDENT & CEO |
316,000 | $0 | 351,700 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 6:57 pm |
N/A 2035-01-17 |
Y-mAbs Therapeutics Inc. | YMAB | LaRocca John SVP, General Counsel & Secry |
64,400 | $0 | 64,400 (Direct) |
View |
Ownership |
2025-01-16 4:44 pm |
N/A 2034-01-18 |
Y-mAbs Therapeutics Inc. | YMAB | LaRocca John SVP, General Counsel & Secry |
0 | $0 | 142,600 (Direct) |
View |
| 2024-09-19 Exercise |
2024-09-20 4:15 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas CHIEF BUSINESS OFFICER |
22,831 | $4.38 | 452,381 (Direct) |
View |
| 2024-09-19 Exercise |
2024-09-20 4:15 pm |
N/A 2026-10-21 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas CHIEF BUSINESS OFFICER |
22,831 | $0 | 452,381 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 4:15 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER |
50,000 | $4.38 | 181,262 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 4:15 pm |
N/A 2026-05-20 |
Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER |
50,000 | $0 | 181,262 (Direct) |
View |
| 2024-07-12 Option Award |
2024-07-12 5:29 pm |
N/A 2034-07-12 |
Y-mAbs Therapeutics Inc. | YMAB | PFREUNDSCHUH PETER P. CFO and Treasurer |
216,000 | $0 | 216,000 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 9:02 pm |
N/A 2034-06-11 |
Y-mAbs Therapeutics Inc. | YMAB | TAGLIAFERRI MARY Director |
18,040 | $0 | 22,700 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 9:02 pm |
N/A 2034-06-11 |
Y-mAbs Therapeutics Inc. | YMAB | Hamill Laura Director |
18,040 | $0 | 20,370 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 9:01 pm |
N/A 2034-06-11 |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director 10% Owner |
18,040 | $0 | 4,579,603 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 9:01 pm |
N/A 2034-06-11 |
Y-mAbs Therapeutics Inc. | YMAB | HEALY JAMES Director |
18,040 | $0 | 2,240,426 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 9:00 pm |
N/A 2034-06-11 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
18,040 | $0 | 20,370 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 9:00 pm |
N/A 2034-06-11 |
Y-mAbs Therapeutics Inc. | YMAB | TYAGI ASHU Director |
18,040 | $0 | 20,370 (Direct) |
View |
| 2024-05-30 Exercise |
2024-05-31 9:36 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, SECRY & TREAS. |
60,000 | $2 | 722,248 (Direct) |
View |
| 2024-05-30 Exercise |
2024-05-31 9:36 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, SECRY & TREAS. |
60,000 | $0 | 722,248 (Direct) |
View |
| 2024-03-12 Option Award |
2024-03-14 5:01 pm |
N/A 2034-03-12 |
Y-mAbs Therapeutics Inc. | YMAB | TAGLIAFERRI MARY Director |
32,560 | $0 | 32,560 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:30 pm |
N/A 2034-02-12 |
Y-mAbs Therapeutics Inc. | YMAB | Rossi Michael J PRESIDENT & CEO |
303,900 | $0 | 303,900 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 6:02 pm |
N/A 2034-01-18 |
Y-mAbs Therapeutics Inc. | YMAB | Rajah Vignesh SVP & CHIEF MEDICAL OFFICER |
53,500 | $0 | 75,566 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 6:00 pm |
N/A 2034-01-18 |
Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER |
53,500 | $0 | 71,300 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 5:58 pm |
N/A 2034-01-18 |
Y-mAbs Therapeutics Inc. | YMAB | Lisby Steen SVP & CHIEF SCIENTIFIC OFFICER |
53,500 | $0 | 71,300 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 5:56 pm |
N/A 2034-01-18 |
Y-mAbs Therapeutics Inc. | YMAB | Wilms Joris SVP & CHIEF OPERATING OFFICER |
53,500 | $0 | 71,300 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 5:54 pm |
N/A 2034-01-18 |
Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER |
53,500 | $0 | 116,962 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 5:52 pm |
N/A 2034-01-18 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas CHIEF BUSINESS OFFICER |
154,600 | $0 | 620,132 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 5:48 pm |
N/A 2034-01-18 |
Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, SECRY & TREAS. |
127,000 | $0 | 319,777 (Direct) |
View |
| 2023-12-21 Exercise |
2023-12-26 4:15 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas Chief Business Officer |
50,000 | $2 | 568,532 (Direct) |
View |
| 2023-12-21 Exercise |
2023-12-26 4:15 pm |
N/A 2025-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Gad Thomas Chief Business Officer |
50,000 | $0 | 568,532 (Direct) |
View |